Mitochondrial peroxidase TPx-2 is not essential in the blood and insect stages of Plasmodium berghei
© Masuda-Suganuma et al.; licensee BioMed Central Ltd. 2012
Received: 2 July 2012
Accepted: 8 November 2012
Published: 12 November 2012
Malaria parasites actively proliferate in the body of their vertebrate and insect hosts, and are subjected to the toxic effects of reactive oxygen species. The antioxidant defenses of malaria parasites are considered to play essential roles in their survival and are thus considered promising targets for intervention. We sought to identify the cellular function of thioredoxin peroxidase-2 (TPx-2), which is expressed in the mitochondria, by disrupting the TPx-2 gene (pbtpx-2) of the rodent malaria parasite Plasmodium berghei.
In three independent experiments, two disruptant populations (TPx-2 KO) and three wild-type parasite populations with pyrimethamine resistance (dhfr-ts/mt at the DHFR-TS locus) and intact pbtpx-2 (TPx-2 WT) were obtained and cloned. Null expression of TPx-2 in the KO population was confirmed by RT-PCR and Western blot analyses. The TPx-2 KO parasite developed normally in mouse erythrocytes and multiplied at a rate similar to that of the TPx-2 WT parasite during the experimental period. The peak period of gametocytemia was delayed by 1 day in the TPx-2 KO compared with that of the TPx-2 WT and the parent parasite, however, the highest gametocyte number was comparable. The number of midgut oocysts in the TPx-2 KO at 14 days post feeding was comparable to that of the TPx-2 WT.
The present finding suggests that mitochondrial Prx TPx-2 is not essential for asexual and the insect stage development of the malaria parasite.
KeywordsPeroxiredoxin Plasmodium berghei Thioredoxin peroxidase
Malaria is a disease caused by infection with protozoan parasites of the genus Plasmodium and transmitted by Anopheles mosquitoes. Almost half of the world’s population lives with a serious risk of contacting malaria, and nearly 1 million people died from the disease in 2010 . Despite years of intensive research, an effective vaccine is still not available, and the parasite displays increasing resistance towards the commonly used anti-malarial drugs. To combat malaria, a better understanding of the basic biology of the parasite is needed, especially with regard to the mechanisms of adaptation to environmental conditions.
As Plasmodium spp. actively proliferate in the erythrocytes of their vertebrate hosts, large quantities of reactive oxygen species (ROS), which damage biological macromolecules, are generated in the cell during parasite development [2, 3]. One of the major sources of ROS in the parasite cell is heme, which is produced as a byproduct of hemoglobin digestion for amino acid procurement . In addition, the parasite possesses a mitochondrion with a functional electron transport chain. During respiration, ROS are generated that need to be removed. ROS also emerge in the cell when the organism is exposed to a variety of stress conditions such as the action of the host immune system . Since Plasmodium spp. are highly susceptible to oxidative stresses, their antioxidant defenses are considered to play essential roles in their development, and they are thus expected to be potential targets for chemotherapy .
Malaria parasites possess six peroxidases localized in the cytoplasm, mitochondrion, apicoplast and nucleus: a 1-Cys Prx, two typical 2-Cys Prxs, a 1-Cys antioxidant protein (AOP), a Prx family with unusual biochemical characteristics and a glutathione (GSH) peroxidase-like thioredoxin peroxidase (TPxGl) [7–9]. Since malaria parasites do not possess catalase and genuine GSH peroxidase in their genome, it is considered that GSH itself is the major redox buffer for transient H2O2 exposure and the basal peroxide flux in the cell is dealt with by the Trx system . It has recently been reported that disruption of the gene for the cytosolic 2-Cys Prx (TPx-1) in Plasmodium renders parasites hypersensitive to ROS and reactive nitrogen species, although it did not affect parasite growth under normal in vitro and in vivo asexual development . Thus far, however, the functions of the Prx family in the organelle are unclear. In the present study, the gene coding for TPx-2, which is expressed in the mitochondrion of the rodent malaria parasite P. berghei (Additional file 1: Figure S1), was disrupted and phenotypes of the disruptant were observed in experimental infections in mice and mosquitoes in order to investigate unidentified cellular function of the Prx family in malaria parasites.
The P. berghei ANKA strain was obtained from the Armed Forces Research Institute of Medical Sciences, Thailand. The parasite was maintained by mosquito transmission in Anopheles stephensi interspersed by a maximum of two serial passages in BALB/c mice (Clea Tokyo, Japan).
For disruption of the pbtpx-2, 5′ and 3′ portions of the gene were amplified by polymerase chain reaction (PCR) and cloned into the targeting vector pMD204 , which was supplied by the Malaria Research and Reference Reagent Resource Center; MR4/ATCC, Manassas, VA, USA. Each fragment contained part of the coding sequence and flanking region and was amplified with sequence-specific primers and parasite genomic DNA. The primers used for the 5′ fragment were 5′GGG CCC CTA TCT GAG TAA TAT CTC ATA TCT CC-3′ and 5′GAG CTC CAT GAG AAA ACG ATC TCA CTG ATC-3′ (Apa I and Xho I sites are underlined). The primers used for the 3′ fragment were 5′GAA TTC GTT TAG ACC CAA TAA TGA GGC-3′ and 5′CTG CAG GTT TTT CAC ACA CAG GAG TTA C-3′ (Eco RI and Pst I sites are underlined). The primers were designed on the basis of sequences in the P. berghei genome database provided by the Plasmodium Genome Resource [PlasmoDB: PBANKA_143080]. PCR products were purified and cloned into the upstream or downstream of the pyrimethamine-resistant form of the P. berghei dihydrofolate reductase-thymidylate synthase gene (dhfr-ts), which was used as a selectable marker. For gene targeting experiments, the plasmid was digested with Apa I and Pst I to separate the linear targeting construct from the plasmid backbone.
Transfection was performed according to the protocol of Janse et al. . To transfect the knock out construct into P. berghei with Nucleofector® (Amaxa, Germany), mature schizonts were prepared. To collect the parasites, ICR mice (Clea Japan) were infected with P. berghei by intraperitoneal (i.p.) injection of 5 x 106 parasitized erythrocytes per animal. The schizont pellet was resuspended in 0.1 ml Nucleofector® working solution containing 9 μg linearized targeting vector, then transferred to electroporation cuvettes for transfection at the U-33 setting. After transfection, 50 μl of complete culture medium was added to the mixture and was immediately inoculated into a mouse per transfection by intravenous (i.v.) injection. The mice were provided with drinking water containing pyrimethamine (0.7 mg/ml) 1 day after infection with transfected parasites. When parasitemia had reached 1-2%, the parasite population in each mouse was examined by allele-specific PCR prior to cloning the parasite population with the wild-type and disruptant allele by limiting dilution. Both parasite genomes were determined by PCR and Southern blot analyses. Null-phenotype for TPx-2 expression was confirmed by reverse transcriptase PCR (RT-PCR) and Western blotting.
Five–week-old female BALB/c mice (CLEA Japan, Japan) were infected with P. berghei (106 parasitized erythrocytes per mouse) by i.p. injection. Parasitemia and gametocytemia were determined by microscopic examination of Giemsa-stained thin blood films. Gametocytes were distinguished by size and coloration. The animal experiments in this study were carried out in compliance with the Guide for Animal Experimentation at Obihiro University of Agriculture and Veterinary Medicine (permission numbers: 21–56 and 22–48).
Six-week-old male BALB/c mice (CLEA Japan, Japan) were infected with P. berghei by i.p. injection of the parasite, which had been stored as frozen stock at −80°C. Parasitemia of each mouse was monitored daily by light microscopic observation of Giemsa-stained thin blood smears. A. stephensi mosquitoes were maintained on 10% sugar solution at 27°C and 80% relative humidity under a 12 hr light/dark cycle. When the number of microgametocytes that could exflagellate in vitro had reached 20–30 per 1 x 105 erythrocytes, the mosquitoes were fed on the mice for 2 h at 19°C. The parasite-infected mosquitoes (100–200 mosquitoes per group) were maintained at 19°C with 10% sugar solution.
At 14 days post-feeding, mosquitoes that had been infected with parasite populations were dissected and their midguts were isolated. The midguts were stained using the improved technique . Briefly, the midguts were stained with 0.5% mercurochrome (Sigma Aldrich Japan, Japan) in water at room temperature for 10 min and washed in PBS for 30 min. Next, stained midguts were fixed with 10% formalin (Wako Pure Chemical, Japan) for 24 h and opened along the median line. The midgut specimens were observed, and the numbers of red-stained oocysts were counted using light microscopy (x 100 or x 200).
Differences were evaluated with the Student’s t-test (mouse infection) or the Mann–Whitney test (mosquito infection). P < 0.05 was considered statistically significant.
Results and discussion
The results presented here suggest that pbtpx-2 disruption does not affect asexual intraerythrocytic growth of parasites. The present findings might be contradicted by the facts that the mitochondria of the rodent malaria parasite, P. yoelii, possess an active respiratory chain  and the mitochondrial peroxide-detoxifying capacity is likely to be provided by Prx . It has also been reported in other organisms that a mitochondrial Trx system plays pivotal roles in defense against oxidative stress generated in the organelle .
In P. falciparum, it had been believed for a long time that the parasite electron transport chain was not a source of ATP, but was essential in the parasite for maintenance of mitochondrial membrane potential, as indicated by their hypersensitivity to proguanil, a drug that collapsed the membrane potential in the presence of an electron transport inhibitor [20, 21]. However, it has been shown recently that metabolism in P. falciparum grown in human patients is affected by varied oxygen and substrate levels and by host-parasite interactions. As a consequence, the parasite seems to induce expression of genes associated with oxidative phosphorylation as a response against starvation status . The parasite may require TPx-2 for development under such stressful conditions. The phenotype of TPx-2 KO during asexual growth under low glucose supply would be an interesting subject of investigation.
Plasmodium mitochondria are morphologically different between the sexual and asexual blood stages . Asexual stage parasites have a tubular-like cristate mitochondrion. In contrast, the mature gametocyte stage has multiple (4–8) mitochondria with greater numbers of cristate structures. The differences suggest that the gametocytes might have a higher demand for energy transduction and are also more metabolically active than the asexual stages . Although the contribution of TPx-2 in gametocyte development remains unknown, the phenotype of TPx-2 KO in the gametocyte stage is thus an interesting subject for further investigation.
The results from phenotype observation in the insect stage suggest that pbtpx-2 disruption does not affect gamete fertilization, ookinete formation and transformation of the ookinetes to oocysts, which requires ookinete invasion of epithelial cells and attachment to the basal lamina of the mosquito’s midgut. However, it has been reported that ookinetes are subject to oxidative stress during their invasion of midgut epithelial cells . In addition, it is postulated that ROS is produced in the motile ookinete stage, when oxygen metabolism in the cell may be elevated. The expression profiles of the molecules of the Prx family in the TPx-2 KO ookinete would also be worth investigating.
The present finding suggests that mitochondrial Prx TPx-2 is not essential for the asexual and insect developmental stages of the malaria parasite. Under more pronounced stress conditions, specific functions of TPx-2 may become evident. An explanation for the lack of phenotype in the TPx-2 KO parasites in the blood and insect-stages might be due to redundancy in the function of the multiple members of the thioredoxin system . A multiple Prx KO clone has not yet been produced in P. berghei. It will be interesting to develop such KO clones in the future to clarify the Prx family, which may functionally overlap with TPx-2 in the malaria parasite.
Reactive oxygen species.
We are very grateful to Dr. A. P. Waters of Glasgow University (Glasgow, Scotland) for providing the targeting vector, pMD204, to the Malaria Research and Reference Reagent Resource Center; MR4/ATCC. We are also grateful to Dr. K. Yano of the National Center for Global Health and Medicine (Tokyo, Japan) and Dr. S. Kanzok of Loyola University (Chicago, USA) for kind advice regarding the gene-targeting experiments and mosquito stage experiments, respectively. This work was supported by a Grant-in-Aid for Scientific Research (20390118 and 23390098) from the Japan Society for the Promotion of Science.
- WHO: World Malaria Report 2011. Summary and Key Points. 2011, WHO, Geneva, X-XII.Google Scholar
- Becker K, Tilley L, Vennerstrom JL, Roberts D, Rogerson S, Ginsburg H: Oxidative stress in malaria parasite-infected erythrocytes: host-parasite interactions. Int J Parasitol. 2004, 34: 163-189. 10.1016/j.ijpara.2003.09.011.View ArticlePubMedGoogle Scholar
- Müller S: Redox and antioxidant systems of the malaria parasite Plasmodium falciparum. Mol Microbiol. 2004, 53: 1291-1305. 10.1111/j.1365-2958.2004.04257.x.View ArticlePubMedGoogle Scholar
- Ginsburg H, Ward SA, Bray PG: An integrated model of chloroquine action. Parasitol Today. 1999, 15: 357-360. 10.1016/S0169-4758(99)01502-1.View ArticlePubMedGoogle Scholar
- Postma NS, Mommers EC, Eling WM, Zuidema J: Oxidative stress in malaria; implications for prevention and therapy. Pharm World Sci. 1996, 18: 121-129. 10.1007/BF00717727.View ArticlePubMedGoogle Scholar
- Krauth-Siegel RL, Bauer H, Schirmer RH: Dithiol proteins as guardians of the intracellular redox milieu in parasites: old and new drug targets in trypanosomes and malaria-causing plasmodia. Angew Chem Int Ed Engl. 2005, 44: 690-715. 10.1002/anie.200300639.View ArticlePubMedGoogle Scholar
- Nickel C, Rahlfs S, Deponte M, Koncarevic S, Becker K: Thioredoxin networks in the malarial parasite Plasmodium falciparum. Antioxid Redox Signal. 2006, 8: 1227-1239. 10.1089/ars.2006.8.1227.View ArticlePubMedGoogle Scholar
- Kehr S, Sturm N, Rahlfs S, Przyborski JM, Becker K: Compartmentation of redox metabolism in malaria parasites. PLoS Pathog. 2010, 6: e1001242-10.1371/journal.ppat.1001242.PubMed CentralView ArticlePubMedGoogle Scholar
- Richard D, Bartfai R, Volz J, Ralph SA, Muller S, Stunnenberg HG, Cowman AF: A genome-wide chromatin-associated nuclear peroxiredoxin from the malaria parasite Plasmodium falciparum. J Biol Chem. 2011, 286: 11746-11755. 10.1074/jbc.M110.198499.PubMed CentralView ArticlePubMedGoogle Scholar
- Kawazu S, Komaki-Yasuda K, Oku H, Kano S: Peroxiredoxins in malaria parasites: parasitologic aspects. Parasitol Int. 2008, 57: 1-7. 10.1016/j.parint.2007.08.001.View ArticlePubMedGoogle Scholar
- van Dijk MR, Waters AP, Janse CJ: Stable transfection of malaria parasite blood stages. Science. 1995, 268: 1358-1362. 10.1126/science.7761856.View ArticlePubMedGoogle Scholar
- Janse CJ, Ramesar J, Waters AP: High-efficiency transfection and drug selection of genetically transformed blood stages of the rodent malaria parasite Plasmodium berghei. Nat Protoc. 2006, 1: 346-356. 10.1038/nprot.2006.53.View ArticlePubMedGoogle Scholar
- Cao YM, Tsuboi T, Torii M: Nitric oxide inhibits the development of Plasmodium yoelii gametocytes into gametes. Parasitol Int. 1998, 47: 157-166.View ArticleGoogle Scholar
- Hall N, Karras M, Rain JD, Carlton JM, Kooij TW, Berriman M, Florens L, Janssen CS, Pain A, Christophides GK, James K, Rutherford K, Harris B, Harris D, Churcher C, Quail MA, Ormond D, Doggett J, Trueman HE, Mendoza J, Bidwell SL, Rajandream MA, Carucci DJ, Yates JR, Kafatos FC, Janse CJ, Barrell B, Turner CM, Waters AP, Sinden RE: A comprehensive survey of the Plasmodium life cycle by genomic, transcriptomic, and proteomic analyses. Science. 2005, 307: 82-86. 10.1126/science.1103717.View ArticlePubMedGoogle Scholar
- Yano K, Komaki-Yasuda K, Tsuboi T, Torii M, Kano S, Kawazu S: 2-Cys Peroxiredoxin TPx-1 is involved in gametocyte development in Plasmodium berghei. Mol Biochem Parasitol. 2006, 148: 44-51. 10.1016/j.molbiopara.2006.02.018.View ArticlePubMedGoogle Scholar
- Yano K, Komaki-Yasuda K, Kobayashi T, Takemae H, Kita K, Kano S, Kawazu S: Expression of mRNAs and proteins for peroxiredoxins in Plasmodium falciparum erythrocytic stage. Parasitol Int. 2005, 54: 35-41. 10.1016/j.parint.2004.08.005.View ArticlePubMedGoogle Scholar
- Uyemura SA, Luo S, Vieira M, Moreno SNJ, Docampo R: Oxidative phosphorylation and rotenone-insensitive malate- and NADH-quinone oxidoreductases in Plasmodium yoelii yoelii mitochondria in situ. J Biol Chem. 2004, 279: 385-393.View ArticlePubMedGoogle Scholar
- Boucher IW, McMillan PJ, Gabrielsen M, Akerman SE, Brannigan JA, Schnick C, Brzozowski AM, Wilkinson AJ, Müller S: Structural and biochemical characterization of a mitochondrial peroxiredoxin from Plasmodium falciparum. Mol Microbiol. 2006, 61: 948-959. 10.1111/j.1365-2958.2006.05303.x.PubMed CentralView ArticlePubMedGoogle Scholar
- Wheeler GL, Grant CM: Regulation of redox homeostasis in the yeast Saccharomyces cerevisiae. Physiol Plant. 2004, 120: 12-20. 10.1111/j.0031-9317.2004.0193.x.View ArticlePubMedGoogle Scholar
- Painter HJ, Morrisey JM, Mather MW, Vaidya AB: Specific role of mitochondrial electron transport in blood-stage Plasmodium falciparum. Nature. 2007, 446: 88-91. 10.1038/nature05572.View ArticlePubMedGoogle Scholar
- van Dooren GG, Stimmler LM, McFadden GI: Metabolic maps and functions of the Plasmodium mitochondrion. FEMS Microbiol Rev. 2006, 30: 596-630. 10.1111/j.1574-6976.2006.00027.x.View ArticlePubMedGoogle Scholar
- Daily JP, Scanfeld D, Pochet N, Le Roch K, Plouffe D, Kamal M, Sarr O, Mboup S, Ndir O, Wypij D, Levasseur K, Thomas E, Tamayo P, Dong C, Zhou Y, Lander ES, Ndiaye D, Wirth D, Winzeler EA, Mesirov JP, Regev A: Distinct physiological states of Plasmodium falciparum in malaria-infected patients. Nature. 2007, 450: 1091-1095. 10.1038/nature06311.View ArticlePubMedGoogle Scholar
- Krungkrai J: The multiple roles of the mitochondrion of the malaria parasite. Parasitology. 2004, 129: 511-524. 10.1017/S0031182004005888.View ArticlePubMedGoogle Scholar
- Han YS, Thompson J, Kafatos FC, Barillas-Mury C: Molecular interactions between Anopheles stephensi midgut cells and Plasmodium berghei: the time bomb theory of ookinete invasion of mosquitoes. EMBO J. 2000, 19: 6030-6040. 10.1093/emboj/19.22.6030.PubMed CentralView ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.